Abstract
ABSTRACT: The effects of the leukotriene antagonist FPL 57231 on the circulation were studied in spontaneously breathing normoxic and hypoxic newborn lambs in order to evaluate the role of leukotrienes in the perinatal control of hypoxic pulmonary vasoconstriction. Hypoxia produced a 58% increase in pulmonary arterial pressure (p < 0.05) and a 37% increase in pulmonary vascular resistance (p < 0.05). Hypoxic pulmonary vasoconstriction was abolished by the prior infusion of FPL 57231. Pulmonary arterial pressure increased by only 8% and pulmonary vascular resistance decreased by 10% from normoxia. The infusion of FPL 57231 during hypoxia-induced pulmonary vasoconstriction reversed the increase in pulmonary arterial pressure (p < 0.05) and pulmonary vascular resistance (p < 0.05). The hypoxia-induced increase in cardiac output was maintained during the infusion of FPL 57231. Leukotrienes may play a significant role in the mediation of hypoxic pulmonary vasoconstriction. Leukotriene inhibition with FPL 57231 may be useful in the management of infants with persistent pulmonary hypertension syndrome.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schreiber, M., Heymann, M. & Soifer, S. Leukotriene Inhibition Prevents and Reverses Hypoxic Pulmonary Vasoconstriction in Newborn Lambs. Pediatr Res 19, 437–441 (1985). https://doi.org/10.1203/00006450-198505000-00006
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-198505000-00006
This article is cited by
-
Antileukotrienes for the prevention and treatment of chronic lung disease in very preterm newborns: a systematic review
Respiratory Research (2021)
-
The role of eicosanoids in paediatrics
European Journal of Pediatrics (1988)
